Viveve Medical (VIVE) Misses Q2 EPS by 18c

Viveve Medical (NASDAQ: VIVE) reported Q2 EPS of ($0.66), $0.18 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $1.56 million versus the consensus estimate of $1.38 million.

For earnings history and earnings-related data on Viveve Medical (VIVE) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• After-Hours Stock Movers: FDX, CBRS, NKE
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity